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Animal health concerns are not new to agriculture and breakthroughs 
occur with regularity, representing advances in technology. Likewise, 
the need for evaluation of new animal health technologies is not new. 
Standard tools such as budgeting, cash flow analysis, systems simula-
tion analysis, and welfare analysis are required to measure benefits 
from new developments in animal health and disease control.
ANIMAL DISEASE CONTROL BENEFITS
Benefits derived from improvements in animal health or disease con-
trol can be diversified and far ranging, affecting producers, consumers, 
agribusinesses, and government agencies. Producers gain from reduced 
animal mortality levels, whereas diseases decrease feed efficiency, re-
productive success, rate of weight gain, labor efficiency, and increased 
treatment and medication costs. Producers also benefit from disease 
control through reduced use of medication and decreased probability 
of self inoculation. Disease control can also reduce production variabil-
ity, resulting in more uniform products and more consistent marketing 
times. Producer losses from farm-originated infections may also be les-
sened, as may losses from animal or animal product condemnation.
Improved control of diseases which are species-specific can benefit 
selected producers by increasing consumer demand based on the confi-
dence that the product is more “wholesome”.
Agribusinesses can benefit from improved animal disease control, as 
meat packers and processors would have a higher quality, more uni-
form product. Consequently, the time required for sorting, handling, 
and disposing of damaged or condemned products would be reduced, 
and health risks for meat inspectors, meat packers, and practitioners 
would be lessened.
ANIMAL DISEASE CONTROL CONCERNS
Consumers clearly benefit from improved animal disease control 
through lower prices, higher quality, and consistency in availability of 
meat and animal products. Consumers are concerned with at least four 
aspects of disease control which relate to product quality: safety of the 
product with regard to natural disease characteristics (lack of bacterial 
infections, zoonotic disease, etc.); safety of the product with regard to 
compounds added or techniques used during production or marketing 
(use of known carcinogens, etc.); humane treatment of animals during 
the production process; and the effects of disease control methods on 
the environment.
The methods of animal disease control influence consumer satisfac-
tion with the product and affect overall consumption patterns. Im-
proved disease control not only reduces the likelihood of problems 
created by natural disease, but also creates a positive product image. 
Consumers are more likely to buy a product they perceive to be free 
from disease or contamination, e g., poultry products free from sal-
monella.
While disease control techniques improve product quality in terms 
of organism levels, they may introduce compounds that create as much 
consumer concern as the disease organisms themselves. For example, 
meat preservatives may have carcinogenic potential, and concerns 
about the safety of meat from animals treated with growth hormones 
or food additives is everpresent.
Despite rigorous testing and careful development procedures, con-
sumers may react negatively to products created using “new” techni-
ques, such as gene splicing.
Many people are concerned about animal physical discomfort 
caused by producing animals through the use of implants, hormone 
treatments, etc. These factors may affect the consumer’s perception 
of quality or acceptability.
Environmental issues as they relate to animal disease control mea-
sures are also a concern. Antibiotic usage and residue levels in animal
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products and the environment have received a lot of public attention. 
Consumers may react to perceived environmental problems by boycot-
ting products or attempting to alter the regulations on product use. An 
understanding of consumer concerns is important in order for scien-
tists to educate the public about disease control methods, thereby 
avoiding adverse public response.
EXTERNALITY, DISEASE CONTROL AND SUSTAINABLE AGRICULTURE
Sustainable agriculture is defined as the development of systems 
which promote responsible natural resource stewardship and long-
term farm profitability. Externalities have an impact on the level of 
sustainability and are intimately related to natural resource use since 
resources such as water, air, and a disease-free environment do not 
have clear property rights. Because property rights are not exclusive for 
many resources, externalities exist when producers do not consider the 
effects of their actions. Members of society and future generations will 
eventually reap the benefits and costs of current natural resource use.
Sustainable systems remain profitable through time by the careful 
use and management of resources. When externalities become a part of 
the decision making process, society's resources are used for the bene-
fit of everyone concerned.
An externality is defined as an action by one individual that affects 
the level of well-being of another individual. Externalities can be both 
positive and negative. For example, a person polluting a stream to 
avoid the high cost of waste disposal does not usually consider the ef-
fects on individuals further downstream, a negative externality.
Externalities from animal disease control are of two types: exter-
nalities created by the spread of disease mechanisms and externalities 
created by the agents used to control disease. Society must deal with 
both of these off-site effects of disease control or non-control in deter-
mining optimal resource allocation.
There are many externalities in animal disease control. For example, 
a farmer who eliminates pseudorabies from the swine herd reduces the 
probability that the neighboring swine or cattle herds will become in-
fected. On the negative side, when a pork producer allows sulfa resi-
dues to be spread in the environment through improper feeding and 
handling procedures, health hazards are created. The most common 
method of ensuring that externalities are taken into account is
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through quantity and pricing regulations, or changes in ownership 
patterns. An example of a quantity regulation is the banning of a parti-
cular chemical, while a tax on its use is a pricing method of control. 
Ownership can be recognized and protected through legal changes 
which, for example, give a downstream firm the right to clean water.
Animal disease control measures in conjunction with sustainable 
agricultural systems can create additional externalities and regulatory 
problems. The reduced use of animal health products due to genetical-
ly improved animals may reduce externalities which result from chem-
ical residue (positive externality). Alternatively, the use of animal 
wastes as fertilizer in a sustainable system may increase the danger of 
groundwater contamination (negative externality). New disease con-
trol techniques, such as genetically engineered vaccines, may help eli-
minate some diseases and lead to environmental improvements (pos-
itive externality), but vaccines may delay the movement toward good 
management practices and increase the disease reservoir in the envi-
ronment through carrier animals not showing clinical signs (negative 
externality). Improved diagnostic tests may reduce the need for pro-
phylactic treatment and the use of environmentally damaging chemi-
cals (positive externality).
Another problem in the chemical treatment of animal diseases is 
that animals develop a resistance to the compound over time. Further-
more, some chemicals destroy both beneficial and harmful organisms 
in the animal. Therefore the benefits of current chemical treatment 
must be balanced against chemical effects on future immunity.
Biotechnology offers the opportunity to reduce the development of 
compound resistance by reducing the need for chemical control 
through (new and improved) disease-resistant genetic material. Natu-
rally immune animal populations are more sustainable than those 
dependent on chemical controls. Unfortunately, animals immune to 
one disease may be more susceptible to others.
Since there are no clear answers as to the effects of new disease con-
trol agents on the environment, agricultural research needs to consider 
both external and internal effects in carrying out cost/benefit analyses 
for new products.
ANIMAL DISEASE CONTROL ADOPTION ISSUES
The adoption of animal disease control technologies involves producer 
evaluation of a number of factors. Forces such as management
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intensity, the availability of information, financing, production sys-
tems, and available resources will all influence the success of disease- 
control technology.
Management intensity—Technological advancements will magnify 
the need for effective and intensive management. (Effective use of 
many animal health products requires improved production manage-
ment and cost efficiency.) Complex technologies require a clear under-
standing of animal biology, integrated production relationships, di-
sease population dynamics, epidemiology and thorough record- keep-
ing practices. Baseline data is needed when evaluating cost- effective 
animal health management decisions that depend on an extensive 
knowledge of production levels.
Operations with inefficient management gain little from adopting 
disease-control techniques, while operations with top-level manage-
ment will be in a position to utilize new technologies effectively. This 
will place a premium on management, emphasizing the differences 
between well- and poorly- managed operations.
Information—Large farm operations have effectively streamlined the 
process of gathering information and are highly specialized. In compa-
rison, smaller producers may have difficulty staying abreast of current 
animal health advancements. Better communication between the pri-
vate and public sectors may improve the dissemination of information, 
but only the highly specialized, large operations will easily internalize, 
gather and organize the complex information base. Other operations 
will need to incorporate the information base from outside sources.
Financial Concerns—Some animal health products will introduce a 
level of instability into the industry during the adoption and adjust-
ment process. Superior business management skills will be necessary 
in order to effectively manage this instability. The successful adoption 
of a technology will be much more likely for operations in a solid finan-
cial position. The upfront cost of information gathering, purchase fees, 
and set up will have an impact on farms, depending on their size. The 
effective use of a product may necessitate using particular production 
facilities that would require remodeling to existing buildings. Survival 
will be difficult for those operations already in a weak financial 
position.
The adoption of technologies will depend partly upon a producer’s 
ability to absorb increased risk levels. The new health management
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strategies may perform very well when all production factors function 
in unison, however, if one of the factors is out of sync, production may 
be dramatically reduced. This further amplifies the increased pressure 
for intensive management to control production variability.
Resource Quality—Animal health products may require improved 
resource quality and they may be more effective in certain types of pro-
duction systems. The production environment may be related to pro-
duct effectiveness.
Specified Products—Some animal health products may lead to the 
production of a specialized product, such as drug or residue-free pro-
ducts. The need for effective marketing to take advantage of product 
premiums would increase, and may require product identification 
from producer to consumer. Open markets typically do not handle 
identification and separation of specialty products well, but the need 
for marketing techniques such as production and/or marketing con-
tracts may evolve.
ANIMAL DISEASE CONTROL METHODS
The basic methods of disease control include: medication, vaccination, 
eradication, and genetic resistance or natural immunity. In some situa-
tions medication and/or vaccination may be low-cost and highly effec-
tive. This may appear to be an easy and highly economical decision, 
while for others, herd condemnation with mandatory slaughter may 
be quite effective and economical.
When evaluating disease control and prevention programs, atten-
tion has to be given to the program’s impact on the breeding herd.
What may appear to be very economical and highly effective may be 
only a short-run phenomena. Evaluation of the system over the long- 
run may lead to different conclusions. For example, herd replacements 
tend to be selected from lines that perform best under the disease man-
agement strategies already in use. These animals perform best under 
vaccination, medication and eradication programs and thus reduce the 
expression of disease resistance (Govora and Spencer, 1983). A selected 
population may perform well under heavy disease control product use, 
but the population may not perform well if the products are with-
drawn from the market.
Eradication programs have been successful for some diseases, how-
ever these tend to be costly. One method of eradication is that of de-
population or slaughtering an entire herd. The economic value of herd
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members that are naturally immune to disease has been overlooked by 
all economic studies to date. These immune animals can be used to 
build a replacement herd for disease resistance. The long-term econo-
mic value of these naturally immune animals may be quite high. The 
mandatory slaughter of breeding livestock may be eradicating multi-
plier animals which are not immune to a specific disease (Warner, et al., 
1987).
Screening animals for disease resistance may bring economic and 
societal benefits. Screening could include genetic screening, serological 
tests, and other diagnostic tests.
ANIMAL DISEASE IMMUNITY
Sustainable agriculture has two concerns: to be economically and envi-
ronmentally sustainable. Improved animal disease resistance has the 
potential to improve profitability and enhance the environment. Ani-
mal health is tied to animal genetics and to an animal’s immune res-
ponse to disease. It has been shown that the major histocompatibility 
complex (MHC) has an influence on an animal’s immune response and 
disease resistance (Dorf, 1981). For example, the economic traits of 
chickens such as survival rate, feed efficiency, egg production, fertili-
zation rate, hatchability and growth rate are also associated with 
MHC (Bacon, 1987). Lamont points to reasons for selecting for genetic 
resistance to disease (Lamont, 1989). Genetic resistance can lead to re-
duced use of vaccinations and other products as well as offering in-
creased protection as vaccinations lose their effectiveness as a result of 
viral irritation. Lamont concludes that a potential exists for improving 
production efficiency and animal health by working with the MHC 
through both conventional breeding and genetic engineering.
Production traits can be positively or negatively associated with 
disease resistance. Govora and Spencer (1983)have indicated that it is 
feasible to improve disease resistance and selected production traits. 
However, disease resistance is typically disease specific; and informa-
tion on the positive and negative relationships is needed.
ANIMAL DISEASE CONTROL COST CASE STUDIES
A National Animal Health Monitoring System (NAHMS) pilot study 
conducted at Ohio State University estimated annual dairy disease 
costs at $ 163 per cow. This included nearly $28 for drugs and biological 
and veterinary services (Miller, 1987). Lost milk production was esti-
mated at $33 per cow. The University of Missouri farm business dairy
Disease Control in Animals
results showed an average per cow cost of $40 in 1985 and $41 in 1986 
for drugs and veterinary services (Bennett, 1986, 1987). The Missouri 
data also pointed out wide farm to farm fluctuations in these costs.
The percentage of herds and animals in the Iowa State NAHMS 
pilot study which had positive titers for selected diseases is shown in 
Table 1. While many of the herds had antibodies to several disease 
agents, little is known about the cost of disease in the form of reduced 
productive efficiency, death loss, etc.
Table 1
Percentage of herds and animals with positive titers for disease.
Positive % herds positive % animals positive
transmissible gastroenteritis 52 24
Mycoplasma byopneumonia 70 43
Hemophilus pleuroneumoniae 89 47
Pseudorabies 15 7
Porcine pervovirus 92 68
Swine influenza 70 43
Eperythrozoenosia 19 3
Swine dysentery 85 27
Data taken from: Owen, W. J. Initial Analysis of a Valid Food Animal Disease Database for 
Iowa. Iowa State Journal of Research, Vol. 62, No. 2, November.
The Iowa State NAHMS pilot study on swine estimated disease 
costs at $12,034 per farm (Owen, 1987). Annual per farm estimates 
ranged from $406 to $54,358. Such a wide range reflects the varying 
size of operations as well as the varying effectiveness of management. 
Monthly costs per sow ranged from a low of $1.50 to a high of $41.80. 
Annual disease costs averaged $8.40 per head of slaughter animal. Pri-
mary losses occurred from pneumonia ($1.26), still birth ($0.87), sal-
monellosis ($0.47), diarrhea ($0.47) and hemophilus ($0.33) (Owen, 
1988). Since these losses represent observable losses, they are likely to 
be underestimated. Losses such as reduced weight gain, reduced litter 
size, etc. typically go unnoticed and are not considered, but for some 
diseases these losses may be large.
The major disease cost is “animal loss” or primary death loss. At 
$4.96 per head of slaughter animal, it represented 59 percent of repor-
ted disease costs ($8.40 per head of slaughter animals). The major costs 
from animal disease are not disease prevention or treatment costs but 
losses from death and reduced animal production efficiency. There-
fore, greater efforts must be made to measure reduced animal produc-
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tivity. Current variables that are studied overlook some of these 
significant disease costs.
Pseudorabies—(PRV; Aujesky’s disease) is a disease of swine with a 
long history in the United States. Beginning in the 1970s, PRV was re-
cognized as a major contributor to large losses in swine herds. Because 
of the increased severity of pseudorabies, there has been a strong effort 
to understand the disease, develop improved methods of control, bet-
ter vaccines and diagnostic tests, and analyze the benefits and costs of 
eradication versus herd by herd control.
In 1984 a pilot project was begun in Marshall County, Iowa, with 
the intent of eradicating PRV from the county. The project also inves-
tigated the costs of three alternative eradication procedures. By using 
data collected from positive herds, the costs of pseudorabies outbreaks 
was also measured.
Table 2
Valuation of losses due to clinical PRV. 
Type of loss cost
Term abortion $348.66
Abortion at 3 months 340.14
Stillborn or mummified hog 37.20
Death of a baby pig 47.63
Death of a growers/finishers 56.90
Open at 60 days (sow sold) 308.97
Open at 60 days (sow rebred) 103.98
Open at 30 days (sow sold) 231.50
Open at 30 days (sow rebred) 39.16
Source: Hallam, Zimmerman, Beran." The Cost of Clinical Pseudorabies in Iowa Swine Herds", 
Iowa State University, Agriculture and Home Economics Experiment Station Cooperative
Extension Service, AS-590, December 1987.
Using pilot project data, Hallam, Zimmerman and Beran (1987) 
evaluated PRV costs and associated cleanup costs. The cost per in-
stance of clinical PRV is reported in Table 2. These losses were then 
multiplied by the occurrence probability from the sample data to de-
termine the expected loss from a PRV outbreak.The losses are reported 
in Table 3. They range from $20 to $40 per sow depending on the 
assumptions used. The results imply that the typical 100 sow herd 
would differ by the sum of $2000 to $4000 from an outbreak.
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Table3
Rale of losses per sow and costs due to clinical PRV.
cost per sow (non-seedstock) cost per sow 
rate of loss non- (seedstock)
Type of loss per sow replacement replacement
Term abortion 0.030 $10.33 $6.22 $36.77
Stillbirths/mummies 0.155 5.77 3.45 18.65
Death of a baby pig 0.361 17.19 9.75 49.81
Death of growers/finishers 0.004 0.26 0.15 $0.66
Open at 60 days (sow sold) 0.008 2.47 1.38 9.52
Open at 60 days (sow rebred) 0.008 0.83 0.80 1.04
Open at 30 days (sow sold) 0.015 3.47 1.47 16.68
Open at 30 days (sow rebred) 0.015 0.59 0.57 0.72
Reduced rate of gain in survivors 0.044 0.29 0.00 0.29
Total per sow (case if sow sold) 39.78 22.42 132.38
Total per sow (case of sow rebred) 35.26 20.94 107.94
Source:Hallam, Zimmerman and Beran. “The Cost of Clinical Pseudorabies in Iowa Swine Herds," Iowa State 
University, Agriculture and Home Economics Experiment Station Cooperative Extension Serivce, AS-590, 
December 1987.
The costs of eliminating PRV from 23 swine herds in Marshall 
County, Iowa, were also estimated using Pilot Project data. Cleanup of 
PRV used depopulation-repopulation methods, test and removal me-
thods and a program of controlled vaccination with offspring segrega-
tion. The details of these plans are discussed in Zimmerman et al. 
(1989), and the results are summarized in Table 4 on the following 
page.
The most expensive plan was depopulation with a per sow herd cost 
of $204. The most economical plan was test and removal with a cost of 
$7.79. The most commonly used plan of offspring segregation had a 
per sow cost of $40.84. While the method of test and removal was very 
inexpensive, it is only appropriate when prevalence within the herd is 
very low. The large cleanup costs, when compared with the costs of an 
outbreak, imply that few infected herds will have the incentive to 
eliminate disease from their herds unless they cannot vaccinate and 
have a high probability of future clinical signs. The infected producer 
may decide to live with PRV and not eliminate the disease since the 
costs of cleanup exceed the expected costs due to future outbreaks.
The producer, however, does not consider the effects of this decision 
on the probability of his neighbor's herd contracting the virus. Eradi-
cation efforts will probably need the cooperation and financial support 
of many producers and the government.
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PRV cleanup costs by method.3
Depopulatlon/repopulation Controlled vacci-
feederhog farrow to test and nation with offspring
finishers n+3finish n=1 removal n=5 segregation n=l4
Table 4
Veterinary services $0.01 $0.88 $0.54 $0.74
Vaccination-vaccine 0.00 46.88 1.75 7.20
labor 0.00 7.50 0.32 0.56
PRV Surveillance-testing & tagging 0.08 9.97 4.51 4.15
labor 0.01 0.95 0.67 0.38
Cleaning and Disinfecting 0.01 10.70 0.00 0.96
Isolation and Segregation 
facilities 0.23 8.73 0.00 0.00
labor 0.05 7.50 0.00 0.23
transportation 0.00 3.95 0.00 0.00
Downtime 0.00 106.60 0.00 0.00
Losses at sales of culled breeders 0.00 0.00 0.00 26.62
Total producer bosts 0.30 145.93 0.99 28.75
Total program costs 0.09 57.73 6.80 12.09
Total costs 0.39 203.66 7.79 40.84
Source: Hallam, Zimmerman and Beran. ‘The Cost of Clinical Pseudorabies in Iowa Swine Herds," Iowa State 
University, Agriculture and Home Economics Experiment Station Cooperative Extension Service, AS-590, 
December 1987.____________________________________________________________________________________
A study of a large swine production operation in North Carolina 
estimated PRV losses at $16.21 per sow farrowed (Kleibenstein, eta/.,
1988). Losses ran for 17 weeks after the outbreak and amounted to 5.28 
percent of the hogs born during the outbreak period of one to four 
weeks. This same study showed the losses from “high loss” disease (pri-
marily transmissible gastroenteritis) to include 14.04 percent of the 
hogs born. Respiratory diseases reduced production levels by approxi-
mately nine percent. With the assumption that a typical swine ope-
ration has 7.8 hogs (U.S. average) per sow, per litter. Pseudorabies 
vaccine cost per hog was $2.09.
The Iowa NAHMS study showed that seven percent of the hogs had 
positive titers for PRV (Owen, 1987). Extrapolating to a national scale, 
if seven percent of the 80 million market hogs produced annually are 
infected with PRV, it means that 5.6 million hogs are infected. If this 
assumption is true and the losses associated with PRV were to be redu-
ced by half, the cost savings would be approximately $5.9 million an-
nually (5.6M hogs x 50% loss reduction x $2.09 [vaccine cost per hog]).
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Using data from the Iowa Pilot Project and other surveys, a benefit 
cost analysis of a national eradication program was completed (Hal- 
lam, etal., 1987). The analysis considered the costs and benefits of a 10 
year eradication plan. It was assumed that states were to follow differ-
ent protocols depending on disease severity. The benefits of eradica-
tion included eliminated clinical disease, vaccination, and reduced 
testing costs. Nonclinical disease costs were not included since the 
data was not available or of questionable quality. The discounted value 
of these benefits was determined to be J 136.4 million using a 10 per-
cent discount rate and $271.5 million using a six percent discount rate. 
The total cost of the program to producers and the government was 
$134.4 million using a 10 percent rate and $155.8 million using a six 
percent rate. The benefit cost ratio was not large, but the program has 
already been undertaken.
Swine slaughter check and panel—A Missouri swine panel study 
showed direct swine health expenditures ranging from $0.59 to $4.59 
per hog (Kliebenstein, etal., 1983). Total confinement and mixed hou-
sing systems tended to have higher per hog expenses. The two leading 
expenses were for pneumonia and atrophic rhinitis prevention and 
control. This range in health expenditure costs is consistent but nar-
rower than that shown in the Iowa State NAHMS report. The Mis-
souri study showed that the primary disease seasons were the fall and 
winter quarters. Forty-eight percent of the hogs in the winter and 40 
percent of the hogs during the fall were reported to have health pro-
blems.
A slaughter check study showed the two primary morbidity events 
in swine were pneumonia and atrophic rhinitis (AR) (Boessen, et al., 
1988). Losses from pneumonia for a “batch" producer averaged $1.09 
per hog. For a continuous producer, losses averaged 1.5 cents per hog, 
per day of $5.48 per hog production space per year. Losses from AR 
were $0.95 per hog in a “batch” production system and 1.3 cents per 
hog per day or $4.75 per hog production space per year in a continuous 
production system.
Biotechnology offers much to the development of sustainable agri-
culture. Benefits of cost effective and sustainable technology are di-
verse, affecting producers, consumers, agribusiness firms and govern-
ment agencies. It must be recognized that some products have both 
benefits and costs associated with their use, and some may reduce
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problems while increasing others. Thus prudent evaluation is needed 
in both the development and use of biotechnological products.
As with many new technologies, there are no clear answers concern-
ing a product’s impact on society and the environment. Nonetheless, 
potential impacts require careful analysis. The potential for catastro-
phes must be properly evaluated if society is to bear risks that may 
provide only a few benefits. Socially optimal disease control measures 
must account for all costs and benefits—the direct as well as the in-
direct and external.
A review of the cost analysis of selected diseases shows that eco-
nomic analysis of animal disease control alternatives are an important 
component of disease control policies. These costs need to be evaluated 
at both the societal and production level.
Producer adoption of animal disease control techniques will involve 
a number of factors, including management intensity, information 
availability, financing, production systems, and available resources. 
These factors will affect producers in different ways, and thus costs 
and benefits are not likely to be distributed evenly.
Animal disease control strategies will not transform below-average 
managers into above-average managers, as many new technologies 
emphasize improved management intensity as a part of the technology 
package. Management strategies should be in place before a product is 
adopted, and this should make implementation smoother. Producers 
need to have healthy management in order to successfully utilize new 
products and technology, and appropriate management information 
needs to accompany the introduction of new technologies.
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